Su Lu

发表

SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer.

Zongguang Zhou, Xiao-Feng Sun, Huiming Sun, 2016, American journal of cancer research.

Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer

Huiming Sun, Fudong Yu, Su Lu, 2015, Journal of Experimental & Clinical Cancer Research.

Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.

Fudong Yu, Su Lu, Hua-mei Tang, 2014, Biochemical and biophysical research communications.

HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5‐FU resistance by a p53‐dependent pathway

Yang Han, Su Lu, Hua-mei Tang, 2018, Molecular carcinogenesis.

Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.

Jian Chen, Su Lu, Hua-mei Tang, 2014, Oncology reports.

Does fetuin-a mediate the association between pro-inflammatory diet and type-2 diabetes mellitus risk?

Su Lu, A. Ayaz, A. Özsoy, 2022 .

Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.

Yang Han, Su Lu, Zhihai Peng, 2015, Oncology reports.

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer

Su Lu, Senlin Zhao, Hua-mei Tang, 2015, Journal of experimental & clinical cancer research : CR.

HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer

Huiming Sun, Yang Han, Su Lu, 2019, Cancer medicine.

Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1

Fudong Yu, Yang Han, Su Lu, 2016, Journal of Experimental & Clinical Cancer Research.

Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway

Huiming Sun, Xisheng Liu, Su Lu, 2018, Journal of Cancer Research and Clinical Oncology.

Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.

Su Lu, Hua-mei Tang, Zhihai Peng, 2014, International journal of clinical and experimental pathology.

A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers

Huiming Sun, Fudong Yu, Yang Han, 2016, Scientific Reports.

Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1

Fudong Yu, Yang Han, Su Lu, 2016, Journal of experimental & clinical cancer research : CR.

Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.

Su Lu, Hua-mei Tang, Zhihai Peng, 2014, Oncology reports.

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer

Su Lu, Senlin Zhao, Hua-mei Tang, 2015, Journal of experimental & clinical cancer research : CR.

Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer

Su Lu, Hua-mei Tang, Zhi-Hai Peng, 2013, Medical Oncology.

Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.

Fudong Yu, Yang Han, Su Lu, 2015, European journal of cell biology.

Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression

Su Lu, Y. Xuan, Meng Zhang, 2023, Cell Death Discovery.

Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer

Huiming Sun, Fudong Yu, Su Lu, 2015, Journal of experimental & clinical cancer research : CR.

An unusual case of melanocytic matricoma in a young pregnant woman

Su Lu, Zhouwei Wu, Jun Song, 2018, The Australasian journal of dermatology.

The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A

Su Lu, Senlin Zhao, L. Ye, 2016, Oncotarget.

Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis

Tao Jiang, Su Lu, Hua-mei Tang, 2013, Medical Oncology.

Secernin-1 Contributes to Colon Cancer Progression through Enhancing Matrix Metalloproteinase-2/9 Exocytosis

Su Lu, Hua-mei Tang, Zhihai Peng, 2015, Disease markers.